Medication-Assisted Treatment

Medication-Assisted Treatment (MAT) is a comprehensive approach to treating substance use disorders—especially opioid or alcohol addiction—that combines FDA-approved medications with behavioral therapy and counseling. The primary goal of MAT is to stabilize brain chemistry, block the euphoric effects of substances, relieve cravings, and normalize bodily functions, enabling individuals to focus on recovery, therapy, and rebuilding their lives.

WHAT IS
MEDICATION-ASSISTED  TREATMENT?

Medication-assisted treatment (MAT) combines FDA-approved medications
to ease withdrawal symptoms and cravings, primarily for opioid and alcohol addiction,
supporting successful long-term recovery. Recovery Unplugged provides various
MAT therapies, including:

Suboxone® – Taken as a pill or extended-release formulation,
like injections or implants.

Vivitrol® – Taken by monthly extended-release injection.

Sublocade® – Taken as an extended-release injection.

Medication-Assisted Treatment (MAT) is not just about medication—
it addresses addiction by combining medication with medical and behavioral
support. Relapse rates for substance use disorders are high, averaging between
40-60%, similar to chronic illnesses like heart disease or diabetes. These relapses
often occur due to persistent cravings and withdrawal symptoms. MAT effectively
addresses these challenges, making it a highly regarded method within
the treatment community..

37%

The decrease in heroin overdose deaths among MAT patients in one landmark study.

33%

The amount of eligible  MAT participants who actually receive care.

How it works

Medication-assisted treatments work by delivering controlled doses
of opioids to help lessen withdrawal symptoms and cravings.

Stabilize Brain Chemistry

MAT stabilizes your brain chemistry, reducing the physical and psychological symptoms of opioid withdrawal by easing your brain's dependence on opioids. It gradually restores normal brain function, preparing you for successful recovery.
Block Opioid Euphoria

MAT medications reduce dopamine release, limiting pleasure from opioids and easing recovery.